US Stock MarketDetailed Quotes

TCBP TC BioPharm

Watchlist
  • 1.3100
  • -0.1200-8.39%
Close Mar 28 16:00 ET
  • 1.3199
  • +0.0099+0.76%
Post 19:53 ET
3.18MMarket Cap-192P/E (TTM)

TC BioPharm Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q3)Sep 30, 2021
(FY)Dec 31, 2020
(Q4)Dec 31, 2020
(FY)Dec 31, 2019
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-160.35%-14.53M
-62.62%-5.58M
-67.45%-2.55M
-1.09M
49.00%-3.43M
-1.52M
-6.73M
Net income from continuing operations
79.25%-3.11M
-126.00%-14.98M
-168.52%-4.52M
---7.3M
3.83%-6.63M
---1.68M
---6.89M
Operating gains losses
-475.26%-15.94M
224,465.20%4.25M
45,841.19%271.05K
--3.97M
-97.40%1.89K
--590
--72.69K
Depreciation and amortization
-5.74%966.17K
-4.66%1.03M
-6.78%250.35K
--249.31K
18.88%1.08M
--268.56K
--904.47K
Other non cash items
107.43%7.13M
1,081.49%3.44M
2,692.96%1.92M
--1.15M
14.80%291.03K
--68.81K
--253.51K
Change In working capital
-2,410.61%-5.83M
-402.61%-232.08K
14.28%-410.55K
---270.81K
104.23%76.69K
---478.92K
---1.81M
-Change in receivables
93.66%-37.5K
-134.22%-591.62K
-953.54%-447.53K
---244.18K
569.96%1.73M
--52.43K
--258.05K
-Change in payables and accrued expense
-183.16%-1.94M
616.02%2.34M
1,548.98%531.65K
--468.04K
884.71%326.56K
---36.69K
---41.62K
-Change in other working capital
-94.30%-3.84M
0.00%-1.98M
0.00%-494.67K
---494.66K
2.56%-1.98M
---494.67K
---2.03M
Cash from discontinued investing activities
Operating cash flow
-160.35%-14.53M
-62.62%-5.58M
-67.45%-2.55M
---1.09M
49.00%-3.43M
---1.52M
---6.73M
Investing cash flow
Cash flow from continuing investing activities
-116.58%-310.2K
30.13%-143.22K
1.87%-52.04K
-30.27K
90.67%-204.99K
-53.03K
-2.2M
Net PPE purchase and sale
-827.03%-185.71K
42.60%-20.03K
-80.48%-8.75K
---9.34K
98.28%-34.9K
---4.85K
---2.03M
Net intangibles purchase and sale
-1.05%-124.49K
27.57%-123.19K
10.15%-43.29K
---20.94K
-0.02%-170.09K
---48.18K
---170.06K
Cash from discontinued investing activities
Investing cash flow
-116.58%-310.2K
30.13%-143.22K
1.87%-52.04K
---30.27K
90.67%-204.99K
---53.03K
---2.2M
Financing cash flow
Cash flow from continuing financing activities
174.19%17.89M
90.22%6.53M
2,538.45%2.61M
2.36M
4.78%3.43M
-107.22K
3.27M
Net issuance payments of debt
-153.93%-3.38M
1,607.73%6.26M
2,538.45%2.61M
--2.36M
-406.39%-415.27K
---107.22K
--135.54K
Net common stock issuance
1,081.97%3.37M
-92.69%285.11K
100.76%1
--0
24.24%3.9M
---131
--3.14M
Proceeds from stock option exercised by employees
--18.81M
--0
----
----
--0
----
----
Net other financing activities
-4,193.96%-908.6K
60.28%-21.16K
--0
--0
---53.27K
--131
----
Cash from discontinued financing activities
Financing cash flow
174.19%17.89M
90.22%6.53M
2,538.45%2.61M
--2.36M
4.78%3.43M
---107.22K
--3.27M
Net cash flow
Beginning cash position
109.45%1.57M
-21.80%748.02K
-36.18%1.55M
--287.99K
-85.66%956.5K
--2.43M
--6.67M
Current changes in cash
280.92%3.05M
487.67%800.89K
100.93%15.62K
--1.24M
96.35%-206.59K
---1.68M
---5.65M
Effect of exchange rate changes
972.22%190.65K
1,040.30%17.78K
150.17%296
--18.76K
96.95%-1.89K
---590
---61.92K
End cash Position
206.89%4.81M
109.45%1.57M
109.45%1.57M
--1.55M
-21.80%748.02K
--748.02K
--956.5K
Free cash flow
-160.21%-14.9M
-57.40%-5.72M
-65.11%-2.6M
---1.12M
59.26%-3.64M
---1.57M
---8.93M
Currency Unit
GBP
GBP
GBP
GBP
GBP
GBP
GBP
Audit Opinions
Unqualified Opinion with Explanatory Notes
Unqualified Opinion with Explanatory Notes
--
--
Unqualified Opinion with Explanatory Notes
--
--
(FY)Dec 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q3)Sep 30, 2021(FY)Dec 31, 2020(Q4)Dec 31, 2020(FY)Dec 31, 2019
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -160.35%-14.53M-62.62%-5.58M-67.45%-2.55M-1.09M49.00%-3.43M-1.52M-6.73M
Net income from continuing operations 79.25%-3.11M-126.00%-14.98M-168.52%-4.52M---7.3M3.83%-6.63M---1.68M---6.89M
Operating gains losses -475.26%-15.94M224,465.20%4.25M45,841.19%271.05K--3.97M-97.40%1.89K--590--72.69K
Depreciation and amortization -5.74%966.17K-4.66%1.03M-6.78%250.35K--249.31K18.88%1.08M--268.56K--904.47K
Other non cash items 107.43%7.13M1,081.49%3.44M2,692.96%1.92M--1.15M14.80%291.03K--68.81K--253.51K
Change In working capital -2,410.61%-5.83M-402.61%-232.08K14.28%-410.55K---270.81K104.23%76.69K---478.92K---1.81M
-Change in receivables 93.66%-37.5K-134.22%-591.62K-953.54%-447.53K---244.18K569.96%1.73M--52.43K--258.05K
-Change in payables and accrued expense -183.16%-1.94M616.02%2.34M1,548.98%531.65K--468.04K884.71%326.56K---36.69K---41.62K
-Change in other working capital -94.30%-3.84M0.00%-1.98M0.00%-494.67K---494.66K2.56%-1.98M---494.67K---2.03M
Cash from discontinued investing activities
Operating cash flow -160.35%-14.53M-62.62%-5.58M-67.45%-2.55M---1.09M49.00%-3.43M---1.52M---6.73M
Investing cash flow
Cash flow from continuing investing activities -116.58%-310.2K30.13%-143.22K1.87%-52.04K-30.27K90.67%-204.99K-53.03K-2.2M
Net PPE purchase and sale -827.03%-185.71K42.60%-20.03K-80.48%-8.75K---9.34K98.28%-34.9K---4.85K---2.03M
Net intangibles purchase and sale -1.05%-124.49K27.57%-123.19K10.15%-43.29K---20.94K-0.02%-170.09K---48.18K---170.06K
Cash from discontinued investing activities
Investing cash flow -116.58%-310.2K30.13%-143.22K1.87%-52.04K---30.27K90.67%-204.99K---53.03K---2.2M
Financing cash flow
Cash flow from continuing financing activities 174.19%17.89M90.22%6.53M2,538.45%2.61M2.36M4.78%3.43M-107.22K3.27M
Net issuance payments of debt -153.93%-3.38M1,607.73%6.26M2,538.45%2.61M--2.36M-406.39%-415.27K---107.22K--135.54K
Net common stock issuance 1,081.97%3.37M-92.69%285.11K100.76%1--024.24%3.9M---131--3.14M
Proceeds from stock option exercised by employees --18.81M--0----------0--------
Net other financing activities -4,193.96%-908.6K60.28%-21.16K--0--0---53.27K--131----
Cash from discontinued financing activities
Financing cash flow 174.19%17.89M90.22%6.53M2,538.45%2.61M--2.36M4.78%3.43M---107.22K--3.27M
Net cash flow
Beginning cash position 109.45%1.57M-21.80%748.02K-36.18%1.55M--287.99K-85.66%956.5K--2.43M--6.67M
Current changes in cash 280.92%3.05M487.67%800.89K100.93%15.62K--1.24M96.35%-206.59K---1.68M---5.65M
Effect of exchange rate changes 972.22%190.65K1,040.30%17.78K150.17%296--18.76K96.95%-1.89K---590---61.92K
End cash Position 206.89%4.81M109.45%1.57M109.45%1.57M--1.55M-21.80%748.02K--748.02K--956.5K
Free cash flow -160.21%-14.9M-57.40%-5.72M-65.11%-2.6M---1.12M59.26%-3.64M---1.57M---8.93M
Currency Unit GBPGBPGBPGBPGBPGBPGBP
Audit Opinions Unqualified Opinion with Explanatory NotesUnqualified Opinion with Explanatory Notes----Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg